1. Elanco to buy Bayer’s animal health business for $7.6 billion — Vanda Pharmaceuticals “perplexed” by FDA rejection of jet lag drug — AstraZeneca's diabetes drug Farxiga helps patients with heart disease and without diabetes in landmark trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Abbott IT